Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Imagion Biosystems Ltd

Healthcare AU IBX

0.017AUD
0.00(0%)

Last update at 2026-06-04T00:09:00Z

Day Range

0.020.02
LowHigh

52 Week Range

0.010.06
LowHigh

Fundamentals

  • Previous Close 0.02
  • Market Cap6.87M
  • Volume59200
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.50305M
  • Revenue TTM0.07M
  • Revenue Per Share TTM-
  • Gross Profit TTM -2.02957M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -4.35012M -2.50424M -16.00799M -9.80721M -6.02471M
Minority interest - - - - -
Net income -4.30946M -2.06696M -12.47392M -9.80919M -8.63921M
Selling general administrative - 1.74M 3.58M 5.52M 3.76M
Selling and marketing expenses - 0.88M 6.70M - -
Gross profit -0.00881M 2.26M -0.27984M 0.47M 0.23M
Reconciled depreciation - 0.39M 1.18M 1.11M 0.40M
Ebit -3.58489M -0.74757M -11.48822M -9.80522M -6.02040M
Ebitda -3.57608M -0.70008M -10.30497M -8.69704M -5.61597M
Depreciation and amortization 0.00881M 0.05M 1.18M 1.11M 0.40M
Non operating income net other - - - - -
Operating income -3.58489M -0.75655M -15.63476M -9.80522M -6.02040M
Other operating expenses 3.58M 3.42M 16.72M 12.70M 8.87M
Interest expense 0.85M 1.14M 1.13M 0.00198M 0.00430M
Tax provision - 0.00000M 0.00000M 0.00000M 0.00000M
Interest income - 0.01M 0.07M 0.03M 0.00890M
Net interest income - -1.13185M -1.05876M -0.14449M 0.00272M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.04066M -0.43728M -3.53408M 0.00198M 2.61M
Total revenue - 2.67M 1.08M 0.47M 0.23M
Total operating expenses 3.58M 3.02M 15.53M 12.70M 8.87M
Cost of revenue 0.00881M 0.40M 5.25M - -
Total other income expense net -0.76523M -1.74768M -0.37323M -0.00198M -0.00430M
Discontinued operations - - - - -
Net income from continuing ops - -2.06696M -12.47392M -9.80721M -6.02471M
Net income applicable to common shares - -2.06696M -12.47392M -9.80721M -6.02471M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2.04M 2.80M 4.59M 9.98M 14.12M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.15M 0.11M 0.30M 0.13M 0.17M
Total liab 4.21M 5.09M 6.46M 5.30M 0.81M
Total stockholder equity -2.16192M -2.28298M -4.68546M 4.68M 13.31M
Deferred long term liab - - - - -
Other current liab 0.45M 0.17M -5.13582M 0.37M 0.33M
Common stock 65.96M 62.54M 59.31M 56.83M 56.83M
Capital stock - - - 56.83M 56.83M
Retained earnings -71.32200M -67.01254M -68.90681M -55.84146M -46.03425M
Other liab - - - 0.00190M 0.00303M
Good will - - - - -
Other assets - - - - -
Cash 1.85M 2.67M 0.23M 4.45M 13.39M
Cash and equivalents - - - - -
Total current liabilities 4.21M 5.09M 5.36M 1.73M 0.78M
Current deferred revenue - - - - -
Net debt 0.72M 0.18M 6.91M 0.16M -13.34775M
Short term debt 2.56M 2.85M 3.55M 1.04M 0.02M
Short long term debt - - - - -
Short long term debt total 2.56M 2.85M 7.14M 4.60M 0.05M
Other stockholder equity - - - 0.88M 0.35M
Property plant equipment - - - 4.99M 0.35M
Total current assets 2.04M 2.79M 0.60M 4.99M 13.77M
Long term investments - - - - -
Net tangible assets - - - 4.68M 13.31M
Short term investments - - - - -
Net receivables 0.03M 0.00089M 0.07M 0.09M 0.03M
Long term debt - - - - -
Inventory - - - 0.32M 0.17M
Accounts payable 1.20M 2.07M 1.59M 0.33M 0.43M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 3.20M 2.19M 4.92M 3.69M 2.51M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.00849M 0.02M 3.98M 4.99M 0.35M
Capital lease obligations - - - 4.60M 0.05M
Long term debt total - - - 3.56M 0.03M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.08M -0.19038M -0.46873M -0.31009M
Change to liabilities - - - 0.00000M 0.08M
Total cashflows from investing activities - 0.08M -0.19038M -0.46873M -0.31009M
Net borrowings - 0.72M 3.50M -0.96482M -0.35925M
Total cash from financing activities 3.24M 3.61M 4.29M -0.96206M 5.15M
Change to operating activities - - - - -
Net income -4.30946M -2.06696M -12.47392M -9.80919M -6.02471M
Change in cash -0.82285M 2.44M -4.21902M -8.94767M 0.19M
Begin period cash flow 2.67M 0.23M 4.45M 13.39M 13.20M
End period cash flow 1.85M 2.67M 0.23M 4.45M 13.39M
Total cash from operating activities -4.04370M -1.27061M -8.31596M -8.70101M -5.06849M
Issuance of capital stock - 3.13M 2.38M 0.00276M 5.51M
Depreciation 0.00881M 0.39M 1.18M 1.11M 0.40M
Other cashflows from investing activities - 0.08M 0.00000M 0.04M -0.09126M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables -0.01492M 0.07M 0.37M -0.19767M -0.03413M
Sale purchase of stock - 3.13M 2.38M 0.00276M -0.00611M
Other cashflows from financing activities - 2.93M -1.59125M -0.96482M -0.35925M
Change to netincome - - - 0.65M 0.50M
Capital expenditures 0.00000M 0.00000M 0.19M 0.51M 0.22M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.74071M 0.07M 2.15M 2.55M 2.63M
Stock based compensation - 0.01M 0.46M - -
Other non cash items 1.00M 0.32M 0.36M 8.70M 5.62M
Free cash flow -4.04370M -1.27061M -8.50634M -9.20833M -5.28732M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IBX
Imagion Biosystems Ltd		 - -% 0.02 - - 94.05 3.84 5.67 -1.9016
SHL
Sonic Healthcare Ltd		 0.03 0.16% 18.82 16.95 13.83 0.89 1.09 1.42 8.36
IDX
Integral Diagnostics Ltd		 -0.02 0.97% 2.04 53.00 13.87 1.03 1.14 1.75 11.21
ACL
Australian Clinical Labs Ltd		 0.01 0.49% 2.04 14.18 11.16 0.51 2.50 0.92 3.72
MVF
Monash Ivf Group Ltd		 - -% 0.71 17.75 13.93 1.03 1.09 1.73 9.15

Reports Covered

Stock Research & News

View All

Profile

Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.

Imagion Biosystems Ltd

Suite 2, Melbourne, VIC, Australia, 3000

Key Executives

Name Title Year Born
Mr. Robert Romeo Proulx Exec. Chairman, Pres & CEO 1958
Mr. Geoff Hollis CFO & Company Sec. NA
Dr. Yalia Jayalakshmi Ph.D. Chief Devel. Officer NA
Mr. Robert Romeo Proulx Interim Executive Chairman 1958
Mr. Geoff Hollis AGIA, BComm, CA CFO & Company Secretary NA
Mr. Robert Romeo Proulx Interim Executive Chairman 1958
Mr. Geoff Hollis AGIA, BComm, CA CFO & Company Secretary NA
Mr. Robert Romeo Proulx Interim Executive Chairman 1958
Mr. Geoff Hollis AGIA, BComm, CA CFO & Company Secretary NA
Mr. Robert Romeo Proulx Interim Executive Chairman 1958

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.